Skip to content

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Prospective, Multi-centric, Comparative, Long-term Clinical Follow-Up Study for the Evidence of Safety and Performance Indicators of the Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04255966
Enrollment
60
Registered
2020-02-05
Start date
2021-04-12
Completion date
2027-06-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Degenerative Osteoarthritis, Femoral Head Avascular Necrosis, Fractures, Hip, Instability of Prosthetic Joint, Osteolysis, Prosthesis Failure, Rheumatic Arthritis

Keywords

Revision of the acetabular implant, orthopaedic surgery, osteolysis, wear particles, cup loosening, malpositioned cup

Brief summary

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Interventions

DEVICEPlasmafit® Revision Structan®

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Sponsors

Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for the cementless Plasmafit® Revision Structan® Hip Endoprosthesis Cup (primary and revision cases, with bone conditions typically demanding a press-fit revision cup) * Written informed consent * Cases where a press-fit cup fixation is possible

Exclusion criteria

* Patients \< 18 years * Pregnant patients * Patients not able to comply with the study demands, i.e. follow-up visits (mentally or physically) * Patient has an infection in the hip joint region

Design outcomes

Primary

MeasureTime frameDescription
Harris Hip Score (Functional results of the operated hip) over timeup to five years postoperativelyThe functional results of the operated hip will be assessed with the Harris Hip Score (HHS) and evaluated over time

Secondary

MeasureTime frameDescription
Survival of the implantup to five years postoperativelyAny removal or exchange of the acetabular cup or the polyethylene inlay is defined as revision. A removal of the stem is not evaluated as acetabular revision but will be documented and evaluated as part of postoperative complications. The revision-free survival will be assessed using the Kaplan-Meier method.
Quality of Life over timeup to five years postoperativelyEQ-5D is a descriptive system of health-related quality of life states consisting of 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression), each of which can take one of three responses reflecting severity (no problems/some or moderate problems/extreme problems).
Radiological Assessment: Osseointegration of the cup over timeat 3 months, 24 months, 5 years follow-upThe acetabular component in AP view is divided into the three regions I-III as defined by DeLee-Charnley. All three regions will be assessed for osteolysis the implant, to allow an estimation of the osseous integration and stability of the implant.
Radiological assessment: Radiographic loosening of the cup over timeat 3 months, 24 months, 5 years follow-upThe acetabular component in AP view is divided into the three regions I-III as defined by DeLee-Charnley. All three regions will be assessed for and radiolucent lines around the implant, to allow an estimation of the osseous integration and stability of the implant.
Technical problems during surgeryIntraoperativeTechnical problems with instruments, implants or containers, instrument related issues
ImpingementIntraoperativeThe incidence of impingement during intraoperative mobilization is documented;
General handling of instruments / containersIntraoperativeComplaints or problems with the handling of instruments, implants or containers, instrument related issues
Complicationsup to 5 years postoperativelyAll complications in the postoperative course are recorded

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORStefan Landgraeber, Prof. Dr.

University Hospital, Saarland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026